Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies... Show more
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The Momentum Indicator moved above the 0 level on July 11, 2025. You may want to consider a long position or call options on PROCF as a result. In of 135 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for PROCF just turned positive on June 20, 2025. Looking at past instances where PROCF's MACD turned positive, the stock continued to rise in of 59 cases over the following month. The odds of a continued upward trend are .
PROCF moved above its 50-day moving average on June 20, 2025 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for PROCF crossed bullishly above the 50-day moving average on July 01, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .